Amarnath Natarajan

34PUBLICATIONS
90CO-AUTHORS
Medical devicesMolecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 26, 2026
Hydrophobic Tag Protein Degraders: An Emerging Therapeutic Strategy for Cancer.

|Apr 13, 2026
MAP3K1: A Multifunctional Kinase at the Crossroads of Cancer Progression and Tumor Suppression.

Lelisse T Umeta, Amarnath Natarajan

|Nov 24, 2025
Surveying the Proteome-Wide Landscape of Mitoxantrone and Examining Drug Sensitivity in BRCA1-Deficient Ovarian Cancer Using Quantitative Proteomics.

Savanna Wallin, Sneha Pandithar, Sarbjit Singh

|May 14, 2025
A Selective MAP3K1 Inhibitor Facilitates Discovery of NPM1 as a Member of the Network.

Lidia Boghean, Sarbjit Singh, Kiran K Mangalaparthi

|Apr 04, 2025
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degraders.

Jayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin

|Feb 22, 2025
The role of Tyr34 in proton coupled electron transfer and product inhibition of manganese superoxide dismutase.

Jahaun Azadmanesh, Katelyn Slobodnik, Lucas R Struble

Pageof 6

Frequent Collaborators

7 joint publications

Sarbjit Singh

6 joint publications

Gloria E O Borgstahl

6 joint publications

Sandeep Rana

5 joint publications

Jayapal Reddy Mallareddy